Brooks Macdonald Grp - Director/PDMR Shareholding

Brooks Macdonald

28/02/2025 16:45

RNS Number : 9494Y

Brooks Macdonald Group PLC

28 February 2025

 

Brooks Macdonald Group plc

(the "Company" and together with its subsidiaries "Brooks Macdonald" or the "Group")

 

Director/PDMR Shareholding

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") in accordance with the UK Market Abuse Regulations. 

 

On 27 February 2025, the Company granted pursuant to the 2018 Brooks Macdonald Long Term Incentive Plan (the "Plan") nil price options (the "Executive LTIP Awards") over the ordinary shares of 1 pence each in the Company (the "Shares") to the following PDMR:

 

PDMR
Number of Shares Over Which Awards are Granted
Katherine Jones, CFO
52,540

 

The Plan has been established to retain and incentivise the Executives in order to deliver our ambitious growth aims and to closely align the interests of executives with those of shareholders (as outlined in the Directors' Remuneration Policy included in the Annual Report and Accounts 2024).

 

Vesting of Awards

The Executive LTIP Awards will only vest and become exercisable to the extent that stretching targets are achieved over the three-year vesting period. The target metrics will be based 50% on underlying, diluted earnings per share, 35% on funds under management growth and 15% based on a basket of environmental, social and governance based metrics. 

 

Further, the Executive LTIP Awards are also subject to continued employment and malus and clawback provisions.

 

Vesting timetable

To the extent that the necessary performance conditions are achieved, the Executive LTIP Awards will vest and become exercisable on 21 October 2027, following the announcement of the Group's results for the year ended 30 June 2027.

 

Holding period

The Executive LTIP Awards shall be subject to a compulsory, holding period of a further two years from the date of vesting, and this is expected to lapse on 21 October 2029.

 

As at today's date, this Award represents 0.32% of the total voting rights of the Company.

 

ANNEX

The notification below, made in accordance with the UK Market Abuse Regulation, provides further details:

 

 

1.
Details of the person discharging managerial responsibilities / person closely associated
(a)
Name
Katherine Jones
2.
Reason for the notification
(a)
Position/status
Chief Financial Officer
(b)
Initial notification /Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Brooks Macdonald Group plc
(b)
LEI
213800WRDF8LB8MIEX37
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1 pence each
ISIN GB00B067N833
(b)
Nature of the transaction
Grant of nil price options over ordinary shares of 1 pence each in the Company
(c)
Price(s) and volume(s)
Volume granted: 52,540
Exercise Price(s): Nil
(d)
Aggregated information
Aggregated volume: n/a
Aggregated price: n/a
Date of the transaction
27 February 2025
Place of the transaction
Outside of a trading venue

 

 

 

Enquiries:

 

Brooks Macdonald Group plc
Andrea Montague, CEO
Katherine Jones, CFO
Alexander Holcroft, Interim Director of Investor Relations
+44 (0)7418 923 061
Singer Capital Markets (Nominated Adviser and Joint Broker)
Charles Leigh-Pemberton / James Moat
+44 (0)20 7496 3000
Investec Bank plc (Joint Broker)
Christopher Baird / David Anderson
+44 (0)20 7597 4000

 

 

LEI: 213800WRDF8LB8MIEX37

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBLGDDCGDDGUI